Atria Investments’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6K Sell
17,439
-8,285
-32% -$19.2K ﹤0.01% 2027
2025
Q4
$61K Buy
25,724
+391
+2% +$1.01K ﹤0.01% 2013
2025
Q3
$72.5K Sell
25,333
-273
-1% -$716 ﹤0.01% 1998
2025
Q2
$59.4K Sell
25,606
-3,170
-11% -$6.77K ﹤0.01% 1974
2025
Q1
$49.5K Buy
28,776
+247
+0.9% +$447 ﹤0.01% 1882
2024
Q4
$47.6K Buy
28,529
+8,095
+40% +$15.6K ﹤0.01% 1843
2024
Q3
$37.4K Buy
20,434
+7,862
+63% +$13.5K ﹤0.01% 1891
2024
Q2
$14.6K Buy
+12,572
New +$15.8K ﹤0.01% 1905

Other funds holding DOUG

Atria Investments's DOUG Position: Q1 2026 in Review

Atria Investments reduced its Douglas Elliman (DOUG) stake by 32% in Q1 2026, selling an estimated $19.2K and leaving 17,439 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Atria Investments first reported a position in DOUG in Q2 2024 and has held it in 8 quarters since. The position peaked at $72.5K in Q3 2025. 131 funds tracked by Wall St. Rank hold DOUG as of Q1 2026.

  • Atria Investments held 17,439 shares of Douglas Elliman worth $28.6K as of Q1 2026.
  • Atria Investments sold 8,285 Douglas Elliman shares in Q1 2026, an estimated $19.2K.
  • Douglas Elliman made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #2027 holding.
  • Atria Investments first reported a position in Douglas Elliman in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Douglas Elliman position peaked at $72.5K in Q3 2025.
  • 131 funds tracked by Wall St. Rank held Douglas Elliman as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.